Telix Pharmaceuticals Ltd (TLX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | N/A | N/A | N/A | -662 |
| Other Investing Activity | -1,822 | -13,610 | -909 | -1,099 | -2,028 |
| Investing Cash Flow | $-1,822 | $-13,610 | $-909 | $-1,099 | $-2,690 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,153 | 172 | 678 | 980 | 1,681 |
| Common Stock Issued | 369 | 2,274 | 1,444 | 510 | 931 |
| Other Financing Activity | -824 | -233 | -261 | -213 | -203 |
| Financing Cash Flow | $1,698 | $2,213 | $1,861 | $1,277 | $2,410 |
| Exchange Rate Effect | -2,764 | 1,342 | -1,240 | 1,552 | -1,343 |
| Beginning Cash Position | 88,321 | 84,649 | 80,328 | 78,119 | 79,675 |
| End Cash Position | 83,961 | 88,321 | 87,196 | 81,494 | 79,139 |
| Net Cash Flow | $-6,098 | $2,330 | $8,107 | $1,823 | $807 |
| Free Cash Flow | |||||